Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
This study is enrolling participants by invitation only.
University of Witwatersrand, South Africa
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Cynthia S Firnhaber, University of Witwatersrand, South Africa
First received: August 20, 2013
Last updated: December 1, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||August 2016|
|Estimated Primary Completion Date:||March 2016 (Final data collection date for primary outcome measure)|